See All Slides - tctmd.com

Slides

Presentation TCT 2025

TCT 240: Integrated Assessment of Coronary Physiology and Plaque Vulnerability Following Resorption of Magnesium-Resorbable Scaffolds

Presenter: Stefano Galli

October 28, 2025

Presentation TCT 2025

TCT 493: Tailored Antiplatelet Therapy in High-Risk Diabetic Patients Undergoing Complex Percutaneous Coronary Intervention: The Prespecified Analysis of TAILORED-CHIP Trial

Presenter: Seong-Bong Wee

October 28, 2025

Presentation TCT 2025

TCT 1052: Identifying High-Risk Pulmonary Embolism Patients Through Combined Hemodynamic and Thrombotic Assessment

Presenter: Marco G. Mennuni

October 28, 2025

Presentation TCT 2025

TCT 1195: Outcomes of Transcatheter Tricuspid Valve Replacement in Patients with Multivalvular Disease: Insights from the TRISCEND II Trial

Presenter: Akhil Narang

October 28, 2025

Presentation TCT 2025

TCT 850: The Continuous Saline Infusion Rate Required to Achieve Maximal Hyperaemia for Catheter-Based Measurements of Absolute Coronary Blood Flow and Microcirculatory Resistance in Severe Aortic Stenosis – The CORFLO-AS Validate Trial

Presenter: Harsh V. Thakkar

October 28, 2025

Presentation TCT 2025

Overview of Invasive Devices for Remote Patient Monitoring: Which Patients Will Benefit the Most

Presenter: Howie Tran

October 28, 2025

Presentation TCT 2025

How to Decide TF Stent vs TCAR vs CEA

Presenter: Peter A. Schneider

October 28, 2025

Presentation TCT 2025

TCT 1188: Patients With Moderate-to-Severe Baseline MR Before TAVR Showed Greater Pronounced Improvements in Specific Echocardiographic Parameters Related to LV Function and Geometry After TAVR: A Systematic Review and Meta-Analysis

Presenter: Mohammad Reza Movahed

October 28, 2025

Presentation TCT 2025

Bioresorbable Scaffolds as a Preferred Treatment for Ruptured Plaques and Younger ACS Patients: Is It Still a Possibility?

Presenter: Maciej Lesiak

October 28, 2025

Presentation TCT 2025

Case Presentation: High Risk Asymptomatic Carotid Stenosis Patient: Paladin, CGuard or “How I usually do it?”

Presenter: Peter A. Soukas

October 28, 2025

Advertisement

Slides

TCT 240: Integrated Assessment of Coronary Physiology and Plaque Vulnerability Following Resorption of Magnesium-Resorbable Scaffolds

TCT 493: Tailored Antiplatelet Therapy in High-Risk Diabetic Patients Undergoing Complex Percutaneous Coronary Intervention: The Prespecified Analysis of TAILORED-CHIP Trial

TCT 1052: Identifying High-Risk Pulmonary Embolism Patients Through Combined Hemodynamic and Thrombotic Assessment

TCT 1195: Outcomes of Transcatheter Tricuspid Valve Replacement in Patients with Multivalvular Disease: Insights from the TRISCEND II Trial

TCT 850: The Continuous Saline Infusion Rate Required to Achieve Maximal Hyperaemia for Catheter-Based Measurements of Absolute Coronary Blood Flow and Microcirculatory Resistance in Severe Aortic Stenosis – The CORFLO-AS Validate Trial

Overview of Invasive Devices for Remote Patient Monitoring: Which Patients Will Benefit the Most

How to Decide TF Stent vs TCAR vs CEA

TCT 1188: Patients With Moderate-to-Severe Baseline MR Before TAVR Showed Greater Pronounced Improvements in Specific Echocardiographic Parameters Related to LV Function and Geometry After TAVR: A Systematic Review and Meta-Analysis

Bioresorbable Scaffolds as a Preferred Treatment for Ruptured Plaques and Younger ACS Patients: Is It Still a Possibility?

Case Presentation: High Risk Asymptomatic Carotid Stenosis Patient: Paladin, CGuard or “How I usually do it?”

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content